Intuitive Surgical ROA 2011-2025 | ISRG
Current and historical return on assets (ROA) values for Intuitive Surgical (ISRG) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Intuitive Surgical ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-09-30 | $2.75B | $19.35B | 14.18% |
| 2025-06-30 | $2.61B | $20.16B | 13.74% |
| 2025-03-31 | $2.48B | $19.22B | 13.69% |
| 2024-12-31 | $2.32B | $18.74B | 13.47% |
| 2024-09-30 | $2.24B | $17.74B | 13.66% |
| 2024-06-30 | $2.09B | $16.65B | 13.37% |
| 2024-03-31 | $1.99B | $15.83B | 13.28% |
| 2023-12-31 | $1.80B | $15.44B | 12.59% |
| 2023-09-30 | $1.52B | $14.71B | 11.10% |
| 2023-06-30 | $1.43B | $13.90B | 10.72% |
| 2023-03-31 | $1.31B | $13.05B | 9.90% |
| 2022-12-31 | $1.32B | $12.97B | 9.87% |
| 2022-09-30 | $1.38B | $13.26B | 10.18% |
| 2022-06-30 | $1.44B | $13.71B | 10.66% |
| 2022-03-31 | $1.65B | $13.68B | 12.54% |
| 2021-12-31 | $1.71B | $13.56B | 13.55% |
| 2021-09-30 | $1.69B | $12.94B | 14.09% |
| 2021-06-30 | $1.62B | $12.30B | 14.22% |
| 2021-03-31 | $1.17B | $11.54B | 10.80% |
| 2020-12-31 | $1.06B | $11.17B | 10.16% |
| 2020-09-30 | $1.05B | $10.62B | 10.45% |
| 2020-06-30 | $1.14B | $10.10B | 11.70% |
| 2020-03-31 | $1.39B | $9.89B | 14.88% |
| 2019-12-31 | $1.38B | $9.73B | 15.49% |
| 2019-09-30 | $1.32B | $9.13B | 15.59% |
| 2019-06-30 | $1.21B | $8.53B | 15.17% |
| 2019-03-31 | $1.15B | $8.24B | 15.18% |
| 2018-12-31 | $1.13B | $7.85B | 15.88% |
| 2018-09-30 | $0.80B | $7.32B | 12.19% |
| 2018-06-30 | $0.81B | $6.85B | 13.12% |
| 2018-03-31 | $0.78B | $6.43B | 13.47% |
| 2017-12-31 | $0.67B | $5.78B | 12.49% |
| 2017-09-30 | $0.91B | $5.65B | 16.39% |
| 2017-06-30 | $0.82B | $5.25B | 14.45% |
| 2017-03-31 | $0.78B | $4.81B | 13.47% |
| 2016-12-31 | $0.74B | $6.49B | 12.43% |
| 2016-09-30 | $0.72B | $6.18B | 13.03% |
| 2016-06-30 | $0.68B | $5.78B | 13.12% |
| 2016-03-31 | $0.63B | $5.31B | 13.05% |
| 2015-12-31 | $0.59B | $4.91B | 13.04% |
| 2015-09-30 | $0.55B | $4.68B | 12.76% |
| 2015-06-30 | $0.50B | $4.36B | 12.50% |
| 2015-03-31 | $0.47B | $4.13B | 12.47% |
| 2014-12-31 | $0.42B | $3.96B | 11.02% |
| 2014-09-30 | $0.44B | $3.65B | 11.53% |
| 2014-06-30 | $0.47B | $3.41B | 12.36% |
| 2014-03-31 | $0.53B | $4.19B | 13.12% |
| 2013-12-31 | $0.67B | $3.95B | 16.69% |
| 2013-09-30 | $0.68B | $3.70B | 16.80% |
| 2013-06-30 | $0.71B | $4.20B | 17.40% |
| 2013-03-31 | $0.70B | $4.24B | 17.94% |
| 2012-12-31 | $0.66B | $4.06B | 17.82% |
| 2012-09-30 | $0.63B | $3.73B | 18.41% |
| 2012-06-30 | $0.57B | $3.63B | 17.92% |
| 2012-03-31 | $0.53B | $3.33B | 18.11% |
| 2011-12-31 | $0.49B | $3.06B | 17.92% |
| 2011-09-30 | $0.46B | $2.75B | 17.93% |
| 2011-06-30 | $0.43B | $2.65B | 17.23% |
| 2011-03-31 | $0.40B | $2.57B | 16.79% |
| 2010-12-31 | $0.38B | $2.39B | 16.97% |
| 2010-09-30 | $0.34B | $2.35B | 16.10% |
| 2010-06-30 | $0.32B | $2.24B | 16.45% |
| 2010-03-31 | $0.29B | $2.02B | 16.65% |
| 2009-12-31 | $0.23B | $1.81B | 14.71% |
| 2009-09-30 | $0.21B | $1.64B | 13.73% |
| 2009-06-30 | $0.20B | $1.50B | 13.90% |
| 2009-03-31 | $0.19B | $1.39B | 13.78% |
| 2008-12-31 | $0.21B | $1.48B | 15.79% |
| 2008-09-30 | $0.20B | $1.37B | 17.06% |
| 2008-06-30 | $0.19B | $1.23B | 17.28% |
| 2008-03-31 | $0.17B | $1.12B | 17.10% |
| 2007-12-31 | $0.15B | $1.04B | 16.64% |
| 2007-09-30 | $0.12B | $0.91B | 15.40% |
| 2007-06-30 | $0.10B | $0.81B | 13.62% |
| 2007-03-31 | $0.08B | $0.72B | 12.73% |
| 2006-12-31 | $0.07B | $0.67B | 12.12% |
| 2006-09-30 | $0.10B | $0.61B | 17.76% |
| 2006-06-30 | $0.10B | $0.57B | 20.19% |
| 2006-03-31 | $0.10B | $0.53B | 21.68% |
| 2005-12-31 | $0.10B | $0.50B | 22.50% |
| 2005-09-30 | $0.06B | $0.43B | 14.80% |
| 2005-06-30 | $0.04B | $0.39B | 11.59% |
| 2005-03-31 | $0.03B | $0.37B | 9.26% |
| 2004-12-31 | $0.02B | $0.35B | 7.22% |
| 2004-09-30 | $0.01B | $0.34B | 2.17% |
| 2004-06-30 | $0.00B | $0.32B | -0.67% |
| 2004-03-31 | $-0.01B | $0.32B | -2.15% |
| 2003-12-31 | $-0.01B | $0.32B | -4.05% |
| 2003-09-30 | $-0.01B | $0.24B | -4.21% |
| 2003-06-30 | $-0.01B | $0.25B | -7.71% |
| 2003-03-31 | $-0.02B | $0.09B | -16.30% |
| 2002-12-31 | $-0.02B | $0.09B | -20.32% |
| 2002-09-30 | $-0.02B | $0.09B | -20.94% |
| 2002-06-30 | $-0.02B | $0.09B | -19.54% |
| 2002-03-31 | $-0.02B | $0.10B | -19.10% |
| 2001-12-31 | $-0.02B | $0.10B | -15.69% |
| 2001-09-30 | $-0.02B | $0.10B | -16.19% |
| 2001-06-30 | $-0.02B | $0.10B | -14.85% |
| 2001-03-31 | $-0.02B | $0.11B | -14.71% |
| 2000-12-31 | $-0.02B | $0.11B | -18.23% |
| 2000-06-30 | $-0.01B | $0.11B | -23.30% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $200.747B | $8.352B |
| Intuitive Surgical Inc designs, manufactures and markets the da Vinci surgical system and related instruments and accessories, which is an advanced robot-assisted surgical system. The surgical system comprises a surgeon's console, patient-side cart, 3-D vision system, da Vinci Skills Simulator and Firefly Fluorescence Imaging. Intuitive Surgical's robot-based da Vinci surgical system enables minimally-invasive surgery that reduces the trauma associated with open surgery. The company also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures.?Additionally, the company sells various accessories comprising sterile drapes and vision products and other items that facilitate use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies. The company operates through three segments: Instruments and Accessories, Systems and Services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $215.059B | 25.55 |
| IDEXX Laboratories (IDXX) | United States | $56.570B | 56.18 |
| Edwards Lifesciences (EW) | United States | $48.391B | 32.45 |
| Alcon (ALC) | Switzerland | $36.485B | 24.49 |
| IQVIA Holdings (IQV) | United States | $35.841B | 19.99 |
| Mettler-Toledo (MTD) | United States | $29.649B | 34.40 |
| STERIS (STE) | Ireland | $25.979B | 26.72 |
| Waters (WAT) | United States | $22.129B | 29.27 |
| DexCom (DXCM) | United States | $21.451B | 29.57 |
| Hologic (HOLX) | United States | $16.481B | 17.35 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.721B | 0.00 |
| Globus Medical (GMED) | United States | $11.330B | 23.56 |
| Penumbra (PEN) | United States | $10.425B | 73.33 |
| Masimo (MASI) | United States | $7.690B | 24.64 |
| Sysmex ADR (SSMXY) | Japan | $6.698B | 21.28 |
| Teleflex (TFX) | United States | $4.835B | 7.70 |
| Glaukos (GKOS) | United States | $4.817B | 0.00 |
| TransMedics (TMDX) | United States | $4.073B | 48.25 |
| Veracyte (VCYT) | United States | $3.296B | 37.57 |
| Alphatec Holdings (ATEC) | United States | $2.941B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.755B | 14.88 |
| Integer Holdings (ITGR) | United States | $2.392B | 11.23 |
| Artivion (AORT) | United States | $2.117B | 97.54 |
| Nihon Kohden (NHNKY) | Japan | $2.067B | 24.67 |
| PROCEPT BioRobotics (PRCT) | United States | $1.776B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $1.686B | 16.34 |
| Beta Bionics (BBNX) | United States | $1.158B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.099B | 0.00 |
| AxoGen (AXGN) | United States | $1.087B | 0.00 |
| IRadimed (IRMD) | United States | $1.073B | 51.11 |
| Pulse Biosciences (PLSE) | United States | $1.048B | 0.00 |
| OPKO Health (OPK) | United States | $1.029B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.938B | 5.08 |
| SiBone (SIBN) | United States | $0.680B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.591B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.555B | 32.29 |
| Pacific Biosciences Of California (PACB) | United States | $0.529B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.521B | 10.40 |
| AngioDynamics (ANGO) | United States | $0.495B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.449B | 0.00 |
| NeuroPace (NPCE) | United States | $0.437B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.427B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.418B | 11.59 |
| Semler Scientific (SMLR) | United States | $0.418B | 3.28 |
| RxSight (RXST) | United States | $0.385B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.327B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.305B | 50.82 |
| Sight Sciences (SGHT) | United States | $0.305B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.294B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.282B | 0.00 |
| 908 Devices (MASS) | United States | $0.265B | 0.00 |
| CVRx (CVRX) | United States | $0.254B | 0.00 |
| Inogen (INGN) | United States | $0.189B | 0.00 |
| Neuronetics (STIM) | United States | $0.156B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.144B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.144B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.138B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.137B | 0.00 |
| Accuray (ARAY) | United States | $0.133B | 0.00 |
| LENSAR (LNSR) | United States | $0.127B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.106B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.094B | 0.00 |
| Hyperfine (HYPR) | United States | $0.084B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.077B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.076B | 0.00 |
| InspireMD (NSPR) | United States | $0.076B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.069B | 0.00 |
| Spectral AI (MDAI) | United States | $0.054B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.038B | 0.00 | |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.028B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.026B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Envoy Medical (COCH) | United States | $0.018B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Solana (HSDT) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.002B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.54 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |